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A B S T R A C T
Lumpy skin disease virus (LSDV) is a poxvirus that causes systemic disease in cattle, resulting in substantial
economic loss to affected communities. LSDV is a rapidly emerging pathogen of growing global concern that
recently spread from Africa and the Middle East into Europe and Asia, impacting the cattle population in these
regions. An increase in research efforts into LSDV is required to address key knowledge gaps, however this is
hampered by lack of suitable cell lines on which to propagate and study the virus. In this work we describe the
replication and spread of LSDV on Madin-Darby bovine kidney (MDBK) cells, and the formation of foci-type
poxvirus plaques by LSDV on MDBK cells. Methods utilising MDBK cells to quantify neutralising antibodies to
LSDV, and to purify LSDV genomic DNA suitable for short read sequencing are described. These research
methods broaden the tools available for LSDV researchers and will facilitate the gathering of evidence to un-
derpin the development of LSD control and prevention programmes.
1. Introduction
Lumpy skin disease virus (LSDV), sheeppox virus (SPPV) and
goatpox virus (GTPV) are the three members of the capripoxvirus
(CPPV) genus within the poxviridae family. All three capripoxvirus
species cause high consequence transboundary diseases in ruminants,
resulting in substantial production losses in both endemic and epidemic
situations (Bolajoko et al., 2019; Casal et al., 2018; Limon et al., 2020;
Molla et al., 2017). LSDV causes disease only in cattle and water buf-
falo, characterized by multifocal cutaneous nodules up to 2 cm in dia-
meter accompanied by weight loss, fever, reduced milk production and
depression. Morbidity varies from 5 to 26 % and mortality from 0.03 to
2 % (Abutarbush et al., 2015; Al-Salihi and Hassan, 2015; Ochwo et al.,
2018; Sameea Yousefi et al., 2016; Sevik and Dogan, 2016; Tasioudi
et al., 2016).
Lumpy skin disease (LSD) was originally described in southern
Africa in the 1920s and subsequently spread throughout the African
continent and into the Middle East. During the 2012–2020 Eurasian
LSD epidemic, the virus spread into Turkey and then south east Europe,
the Caucasus, Russia, Kazakhstan and into India and Bangladesh. This
recent and unprecedented expansion of the geographical range of LSDV
has highlighted the need for greater research efforts into this rapidly
emerging pathogen, and new and improved methods to underpin these
efforts.
LSDV has a narrow range of cell culture permissibility. It has tra-
ditionally been grown on primary cells of ruminant origin such as lamb
testis cells, fetal bovine muscle and fetal bovine skin cells (Binepal
et al., 2001; OIE, 2019). However, primary cell lines are prone to
contamination, time consuming and expensive to produce, and not
compatible with current efforts to reduce the use of animals in science.
A continuous ovine testis cell line, OA3.Ts, has been shown to support
propagation of LSDV (Babiuk et al., 2007) however this cell line grows
slowly, has a limited passage number, and its pestivirus status is un-
clear. There are also a growing number of reports of LSDV propagation
on Madin-Darby bovine kidney (MDBK) cells (Moller et al., 2019;
Munyanduki et al., 2020; Wallace and Viljoen, 2002).
This study details the growth and spread of LSDV in MDBK cells,
including the formation of foci-type poxviral plaques. We describe new
methods to quantify LSDV neutralizing antibodies in bovine sera, and to
extract and purify genomic LSDV DNA suitable for short read sequen-
cing.
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2. Materials and methods
2.1. Cells and viruses
MDBK cells (p162) obtained from the European Collection of
Authenticated Cell Cultures (Public Health England) were grown in
Dulbecco’s Modified Eagle’s Medium (DMEM; Life Technologies) cul-
ture medium supplemented with 100 IU/mL penicillin (Gibco), 100 μg/
mL streptomycin (Gibco), and either 10 % or 2.5 % fetal bovine serum
(FBS; APS/Life Science Group). Cells were propagated at 37 °C in a 5 %
CO2 incubator.
Primary fibroblast cell cultures were isolated from the ears of
8−12-week-old Holstein Friesian cattle. Three cm2 biopsies were taken
from the lower ear lobe, washed three times in sterile water and shaved
using a disposable sterile scalpel blade (No. 24; Scientific Laboratory
Supplies). Using the scalpel blade, the skin was carefully excised from
the cartilage, cut into 0.5 cm wide strips and placed in 6-well plates
containing culture medium (DMEM supplemented with 100 IU/mL
penicillin 100 μg/mL streptomycin and 5ug/mL amphotericin B
(Sigma) and 10mg/mL Dispase II (Sigma) at a ratio of 3:2 v/v med-
ium:dispase. Tissues samples were then incubated for 17 h overnight at
4 °C. The following day, the epidermis was peeled away from the dermis
using sterile forceps, and the dermis placed on a petri dish containing
culture medium only and cut into 0.5 cm2 square pieces. The tissue
pieces were dipped in culture medium supplemented with 10 % FBS
and placed into 12-well tissue culture plates with the epidermis side
facing down. To each tissue piece, 2–3 drops of culture medium sup-
plemented with 10 % FBS were added and incubated overnight at 37 °C
in a 5 % CO2 incubator. The following day, 8mL of culture medium
supplemented with 10 % FBS was added to each plate. The medium was
changed at 48 h and tissue pieces removed from the wells at 72 h.
Attached fibroblast cells were cultured to 80–100 % confluence fol-
lowed by trypsinisation (0.25 % Trypsin-EDTA; Life Technologies) and
growth in 6-well plates.
LSDV wildtype was isolated from a diseased animal in Cameroon,
Africa, and submitted to the OIE LSDV Reference Laboratory at the
Pirbright Institute on the 22/08/2006 (POX-V1-16-06). LSDV Neethling
strain is an attenuated vaccine strain and has been described previously
(Kara et al., 2003). Unless otherwise specified, the experiments pre-
sented here were carried out with LSDV that had been semi-purified
through a 36 % sucrose cushion. Briefly, MDBK cells were grown in
T175 cm2 tissue culture flasks to 80–90 % confluence in culture
medium supplemented with 2.5 % FBS. The cells were infected at a low
MOI (0.01) and incubated at 37 °C in a 5 % CO2 incubator for 7 days.
The cell pellets were collected, resuspended in 10mM Tris-HCl buffer
(pH 9; Sigma) and lysed using a Dounce homogeniser. Culture super-
natants were layered on 18mL of 36 % sucrose in 32mL OptiSeal tubes
(Beckman Coulter) and centrifuged at 13,500 rpm for 80min in an
Optima™ L-100 XP Ultracentrifuge using a SW-28 rotor (Beckman
Coulter). Supernatants were discarded, and virus pellets resuspended in
500 μL of 10mM Tris-HCl buffer (pH 9) and stored at −80 °C. Purified
virus was sonicated for 30 s at ∼160W using a cup horn sonicator
(Misonix 3000) before use in downstream assays.
2.2. Antibodies and sera
The polyclonal anti-LSDV074 antibody was a kind gift from IDvet
(France). The sera used in the neutralization assays were collected from
five calves at 21 days post-challenge with LSDV (Sanz-Bernardo et al.,
2020).
2.3. Single-step and multi-step growth curves
Cells were infected with LSDV at a MOI of 5 (single-step) or 0.01
(multi-step) for 1 h at 37 °C in a 5 % CO2 incubator. The inoculum was
removed (time point 0 h) and cells washed three times with culture
medium (DMEM, 100 IU/mL penicillin and 100 μg/mL streptomycin
and 2.5 % FBS). At subsequent indicated time points, cells were either
scraped into the supernatant or the cell pellet and supernatant were
collected separately before being titrated on MDBK cells.
Viral titration was assessed using plaque assay and expressed as
number of plaque forming units (PFU)/mL. Briefly, MDBK cells were
cultured in 6-well plates to 80–90 % confluence. Tenfold serial dilutions
were prepared in culture medium from each time point; cell monolayers
were infected with 1mL of each serial dilution and incubated for 1 h at
37 °C in a 5 % CO2 incubator. The inocula were then removed, and cells
overlaid with a 1:1 solution of 2X DMEM (Merck Millipore) supple-
mented with 100 IU/mL penicillin and 100 μg/mL streptomycin, 2 %
sodium pyruvate, 5 % sodium bicarbonate and 5 % FBS) and 3 % car-
boxylmethylcellulose (Sigma). After 7-day incubation at 37 °C in a 5 %
CO2 incubator, the overlay was removed, cells stained with 5 % crystal
violet in 20 % methanol (Sigma) for 1 h at RT and washed with tap
water. Stained plates were allowed to air dry at RT overnight before
plaques were counted microscopically. Virus titer was determined as
the number of plaques counted at the highest dilution (PFU/mL).
2.4. Immunofluorescence
MDBK cells were infected with LSDV and incubated at 37 °C in a 5 %
CO2 incubator for 4 days before being fixed with 4 % paraformaldehyde
(Sigma) at RT for 15min. Fixed cells were washed three times with PBS,
permeabilized with 0.2 % TritonX100 and washed again before label-
ling with primary and secondary antibodies. The anti-LSDV074 anti-
body was diluted 1:500 in blocking buffer (2 % FBS in PBS) and added
to cells. After 1 h incubation at 37 °C, cells were washed and incubated
again for 1 h with a 1:1000 dilution of a goat anti-rabbit IgG (H+L)
antibody (Abcam). Cells were washed three times before coverslips
were mounted on slides.
2.5. Immunofluorescent virus neutralisation test (IFVNT)
MDBK cells were seeded in 24-well tissue culture plates (Corning) at
a cell suspension of 4× 105 cells/mL and incubated overnight at 37 °C
in a 5 % CO2 incubator. All test, positive and negative control sera were
heat inactivated at 56 °C for 30min. Each serum was diluted 1:10 in
culture medium (DMEM supplemented with 50 IU/mL penicillin,
50 μg/mL streptomycin and 2.5 % heat inactivated FBS). Twofold serial
dilutions (1:10 to 1:1280) were then prepared from the test sera. To all
serum samples, an equal volume (300 μL) of LSDV Neethling (700 PFU/
mL) was added, and samples incubated at 37 °C for 1 h in a 5 % CO2
incubator. In addition to the serum controls, a mock cell control and a
virus only control was prepared. All test, positive and negative control
sera were tested in duplicate. 250 μL of the test and control samples
were added to MDBK cells at corresponding wells. Cells were incubated
at 37 °C in a 5 % CO2 incubator for 4 days. All cells were fixed with 4 %
paraformaldehyde (Sigma) and incubated at RT for 15min. Cells were
washed 3 times with PBS, permeabilised with 0.2 % Triton X-100
(Sigma) and incubated for 5min at RT before washing again as de-
scribed. To each well, 250 μL of anti-LSDV074 antibody (IDvet) diluted
1:500 in blocking buffer (2 % FBS in PBS) were added, and cells in-
cubated at 37 °C for 1 h in a 5 % CO2 incubator. Wells were washed as
described and cells incubated at 37 °C for 1 h in a 5 % CO2 incubator
with 250 μL of goat anti-rabbit IgG (H+L) (Abcam) diluted 1:1000 in
blocking buffer. Wells were washed as described before counting the
number of foci under a fluorescent light microscope (Olympus CKX53).
A cut off of 50 foci per/well was used for negative samples. The neu-
tralizing antibody titer was determined as the highest dilution at which
no foci were identified indicating complete neutralization.
2.6. Purification and sequencing of LSDV DNA
LSDV was purified using a protocol adapted from (Hughes et al.,
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2017). Infected MDBK cells were scraped from T175 cm2 flasks and
centrifuged at 2000 rpm for 10min to pellet cells. The supernatants
were discarded, and the pellets resuspended in 20mL of 1mM Tris-HCl
pH9. Suspensions were sonicated 3 times for 1min in a cup horn so-
nicator. Samples were vortexed and kept on ice for 30 s between each
sonication. To each sample, 5 μL of Benzonase® (> 250 units/μl, Sigma)
were added, followed by incubation for 30min at RT. Samples were
centrifuged at 2000 rpm for 10min, the supernatants were collected
and carefully layered over 5mL of a 36 % sucrose solution in 1mM Tris-
HCl pH9 in a 32mL OptiSeal tube (Beckman Coulter) and centrifuged at
13,500 rpm for 80min in an Optima™ L-100 XP Ultracentrifuge using a
SW-28 rotor. Supernatants were discarded, pellets resuspended in 3mL
of 1mM Tris-HCl pH9 and sonicated as above before being layered over
1mL of a 36 % sucrose in 1mM Tris-HCl pH9 in a 5mL OptiSeal tube
(Beckman Coulter). Samples were centrifuged at 15,700 rpm for 80min
in a SW-55 rotor (Beckman Coulter), supernatants were discarded, and
the pellets resuspended in 500 μL of 1mM Tris-HCl pH9 in a nuclease-
free tube (Eppendorf). Samples were then treated with 33 μL of 1.5 M
Tris pH 8.8, 50 μL of 10 % SDS, 100 μL of 60 % sucrose in 1mM Tris-
HCl pH9 and 85 μL of proteinase K (20mg/mL, Thermo Fisher Scien-
tific) for 4 h at 37 °C, followed by phenol-chloroform extraction and
ethanol precipitation. Precipitated DNA was resuspended in a suitable
volume of nuclease-free water. DNA concentration was determined
using a Qubit™ dsDNA HS Assay Kit (Invitrogen) and read in a Qubit 3.0
fluorometer (Invitrogen). Prior to library preparation, nucleic acid QC
was performed using a Bioanalyser 2100 and a high sensitivity DNA kit.
Samples were diluted to 0.2 ng/μl in 10mM Tris-HCl and 5 μL of diluted
dsDNA was used for sequencing library preparation using the Nextera
XT library preparation kit, automated on a Hamilton NGSstar. After
bead normalization, the sequencing library pool was diluted to 12.5 pM
and loaded onto an Illumina MiSeq 2× 150 cycle paired end sequen-
cing run.
2.7. Bioinformatic analysis
Short read sequences from MiSeq were filtered and trimmed, and
reads mapped to the host genome, Bos Taurus reference genome ARS-
UCD1.2 were identified and removed using BBTool (Bushnell, 2020).
Burrows-Wheeler Aligner (BWA) was used to map the remaining reads
to the LSDV reference genome (KX894508.1) using (BWA), from which
coverage was estimated (BBTools). BCFtools (Danecek and McCarthy,
2017), Freebayes (Garrison and Marth, 2012)and Mosdepth (Pedersen
and Quinlan, 2018) were used to generate the consensus genome se-
quence, and each genome was annotated with the reference genome
annotation using Genome Annotation Transfer Utility (GATU)
(Tcherepanov et al., 2006).
3. Results
3.1. LSDV forms foci on MDBK cells
In order to determine the permissivity of MDBK cells for LSDV, a
wildtype strain isolated from clinical material was inoculated onto
MDBK cells, and the cells examined microscopically. Typical poxvirus
cytopathic effect (CPE) was noted (Sanderson et al., 1998), character-
ized by cells becoming rounded and refractile then developing irregular
shapes with long, thin projections (Fig. 1A and B). No secondary pla-
ques forming comet tails, as seen in vaccinia virus infected cell cultures
under liquid overlay (Law et al., 2002), were seen.
At 7 d post inoculation the cells and supernatant were collected
together and LSDV semi-purified by breaking open the cells, clarifying
the lysate, and centrifuging it through a 36 % sucrose cushion. The
semi-purified virus stock was then titered in a ten-fold dilution series on
to MDBK cells. After incubation for 7 d cells were examined micro-
scopically. Multifocal areas of hyperplastic cells, approximately
250–300 cells in each focus, were scattered throughout the wells. The
foci were visible under bright field and enhanced by crystal violet
staining (Fig. 1C). The number of foci in each well decreased by a factor
of ten in accordance with the dilution series. No foci were present in
uninfected wells.
In order to confirm that the hyperplastic foci contained LSDV-in-
fected cells a rabbit polyclonal antibody raised against LSDV074 (the
predicted LSDV orthologue of the vaccinia virus protein H3) (Tulman
et al., 2001) were used to label LSDV infected cells. Briefly, MDBK cells
were infected with LSDV at a low MOI in order to produce individual
foci. Cells were then permeabilised, antibody added, and labelled cells
visualised using fluorescence microscopy. As seen in Fig. 1D–G the
hyperplastic foci were labelled with the anti-LSDV074 antibody. No
labelling was identified in MDBK cells that were not part of a foci. This
indicates that the foci that form on MDBK cells in response to LSDV
infection are composed of LSDV-infected cells.
3.2. LSDV replicates to high titers on MDBK cells
In order to compare virus replication a wildtype strain of LSDV was
Fig. 1. LSDV forms foci on MDBK cells. (A-B) MDBK cells were mock infected
(A) or infected with LSDV (B) at a MOI of 5 then incubated for 24 h. (C) LSDV
was titred on to MDBK cells and incubated for 7 days before being stained with
crystal violet stain to highlight viral foci. Scale bar =200 μm. (D-G) LSDV was
titred on to MDBK cells and incubated for 7 days before being labelled with
antisera raised against LSDV074. Corresponding brightfield (D and F) and
fluorescent (E and G) images are shown. The scale bar in D and E is 200 μm, in F
and G 50 μm.
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inoculated on to MDBK cells and primary bovine fibroblasts at a MOI of
5 and incubated for 7 d (Fig. 2A). Cells and supernatant were collected
together at the indicated times post infection and titred on MDBK cells.
As reported previously, LSDV growth was detected on bovine primary
fibroblasts with approximately 1.5log10 growth rate detected by day 2
post infection. LSDV also replicated well on MDBK cells with approxi-
mately 2.5log10 growth rate by day 2 post infection. This indicates that
MDBK cells are able to support growth of LSDV to a higher titer than
primary bovine fibroblasts.
The growth of LSDV on MDBK cells was then examined in more
detail. Wildtype and attenuated (Neethling) strains of LSDV were in-
oculated on to MDBK cells at a low (0.01) and high (5) MOI. A low MOI
results in a multi-step growth curve that measures multiple rounds of
virus replication and virus spread, while the high MOI infection is a
single-step growth curve that measures just one cycle of virus replica-
tion. For both growth curves supernatant and cell pellet were collected
separately at the indicated time points and titred on MDBK cells
(Fig. 2B and C). The cell pellet was predicted to contain predominantly
intracellular mature virions (IMVs) while the supernatant would con-
tain both extracellular enveloped virions (EEVs) and IMVs that had
been released from lysed cells. In both growth curves in both cellular
and supernatant fractions, the two virus strains tested showed similar
growth kinetics. The amount of virus present in the cellular fraction of
the LSDV single-step (MOI=5) growth curve increased by 2log10 PFU/
mL over 2 d. LSDV was first detected in the supernatant of the one-step
growth curve at 1 d post infection and then increased by over 5log10
PFU/mL at 3 d post infection. The amount of LSDV in the multi-step
growth curve increased by over 5log10 over 2–3 d in both the cellular
and supernatant fractions. The amount of virus detected in the cellular
fraction of the attenuated virus strain was higher than the wildtype
strain at 1 d post infection, however this difference was not apparent at
later timepoints.
3.3. Development of an immunofluorescent virus neutralization test
(IFVNT)
The identification of LSDV foci formation on MDBK cells (Fig. 1C)
suggested a plaque reduction neutralization test (PRNT) could be de-
veloped. A PRNT is a standard method used for detection of ortho-
poxvirus neutralizing antibodies (Putz et al., 2006). In order to develop
a PRNT for LSDV, sera from five calves experimentally inoculated with
LSDV were analysed. The experimental study has been described pre-
viously (Sanz-Bernardo et al., 2020). Briefly, one calf (#1) was not
inoculated and served as a negative control. The remaining four ani-
mals were inoculated with 3×106 PFU of wildtype LSDV. Two calves
developed multifocal cutaneous nodules characteristic of LSD (#3 and
#5) while two calves (#2 and #4) remained clinically normal. In order
to quantify the neutralizing antibodies present in the sera at 21 days
post inoculation LSDV Neethling (2.1× 102 PFU) was mixed with serial
dilutions of the sera. The dilutions were then mixed with MDBK cells
and plated on a 24-well plate. After 4 days the wells were labelled with
anti-LSDV074 antibody and an appropriate fluorescently-labelled sec-
ondary antibody and the foci counted (Fig. 3). Greater than 50 LSDV
foci were present even at the lowest serum dilution of 1:10 in the non-
inoculated control animal (calf #1), indicating that no neutralizing
antibodies were present in the sera. In contrast neutralizing antibodies
were detected in sera from all four inoculated animals (calves #2-#5).
Only a small number of foci formed after virus was added to sera from
the two clinical calves (#3 and #5) even at the highest sera dilution
(1:1280). In comparison greater than 50 foci were present at this
Fig. 2. LSDV replicates and spreads on MDBK cells. (A) MDBK cells (n= 12) or bovine primary fibroblasts (n= 6) were inoculated with LSDV (MOI=5). At the
timepoints shown cells were scraped into the supernatant and virus titred on MDBK cells. Values shown are means, error bars are SEM. (B and C) MDBK cells were
inoculated with LSDV wildtype (B) or LSDV Neethling (C) at a MOI of 5 (one-step growth curve) or MOI= 0.01 (multi-step growth curve). At the timepoints shown
virus loads in the cell associated (PEL) and supernatant (SUP) fractions were determined by plaque assay on MDBK cells. Values are the mean of two biological
replicates, error bars= SEM.
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dilution when sera from the two subclinical calves (#2 and #4) were
examined. The neutralization titre, measured as the highest dilution at
which total neutralization occurs, was 320 for calves #3 and #5, and
160 for calf #4 and 20 for calf #2. Overall, the IFVNT was quicker to
carry out and less subjective than the traditional serum neutralization
test. It discriminated between inoculated and non-inoculated calves and
revealed that the two clinical calves developed higher titers of neu-
tralizing antibodies than the two subclinical calves.
3.4. Optimization of a method for purifying LSDV genomic DNA for whole
genome sequencing
Sequencing of the entire genome of poxviruses is used for molecular
epidemiological studies and to compare the evolution of viruses over
time. We used MDBK cells to adapt a published protocol for variola
virus purification suitable for use in high-containment laboratories
(Hughes et al., 2017). Briefly MDBK cells infected with LSDV were lysed
by sonication in a hypotonic buffer, treated with Benzonase® and virus
particles purified through sequential sucrose cushion ultracentrifuga-
tions, followed by protease digestion of virus cores and phenol-
chloroform extraction and ethanol precipitation of viral DNA. The
concentration of DNA (n=14) recovered from 1 x T175cm2 flask of
original starting material was 6.99 ng/μl in a total volume of 100 μL as
measured by the Qubit. Sequencing libraries were generated using 1 ng
of dsDNA in a 5 μL input volume using the Nextera XT library pre-
paration kit. Libraries were checked by Bioanalyser 2100 using a high
sensitivity DNA kit at the post amplification stage before continuing to
normalization. The final normalized pool of libraries was sequenced
using an Illumina MiSeq on a 2× 150 cycle paired end run. Analysis of
data from three experiments showed that after the removal of adaptors
and lower quality reads, 34–41 % of the sequencing reads mapped to
the host genome. After the removal of reads that mapped to the host
genome, an estimated 32–148 fold coverage was achieved when
mapped against LSDV genome, covering 98.9–99.95 % of the genome in
the three runs. GATU was able to annotate all genes from the reference
genome annotation on each of the consensus sequence genomes gen-
erated from the alignment, with an average of 97.7–99.9 % protein
similarity.
4. Discussion and conclusions
There are few cell lines described in the literature for propagating
capripoxviruses including LSDV. LSDV has traditionally been grown on
primary cell lines such as lamb testis cells or primary bovine fibroblasts
or the ovine testes cell line OA3.Ts. However primary cells and OA3.Ts
are slow to grow, have a restricted growth passage number, and are
prone to contamination. We examined MDBK cells as an alternative cell
line for LSDV propagation.
MDBKs are a ruminant adherent cell line originating from the bo-
vine kidney and showing epithelial characteristics. This cell line was
chosen for its bovine origin, rapid growth characteristics, and amen-
ability to CRISPR/Cas9 modification. Our research showed LSDV pro-
duces characteristic poxvirus CPE in infected MDBK cells including the
formation of distinctive elongated cellular projections. When titrated on
MDBK cells, LSDV formed foci-type plaques similar to that formed by
the leporipoxviruses Shope fibroma virus (Sabourdy et al., 2004) and
myxoma virus (Irwin and Evans, 2012), and the orthopoxviruses ta-
terapoxvirus and variola virus minor (Lourie et al., 1975). In contrast,
poxviruses such as vaccinia virus and cowpox virus typically produce a
viral plaque that has a centrally cleared area surrounded by a rim of
cells exhibiting CPE. The mechanisms underpinning the type of plaque
formed by poxviruses are not fully understood, however inserting the
VACV F11 L ORF into the myxoma virus genome resulted in a change
from a foci to a cleared plaque phenotype, suggesting the F11 protein
influences the plaque morphology of poxviruses (Irwin and Evans,
2012).
A plaque-based titration assay for LSDV was developed and used to
compare growth of LSDV on MDBK cells and primary bovine fibro-
blasts. LSDV was found to grow to slightly higher titers in MDBK cells,
indicating that they are suitable for propagating LSDV. Detailed char-
acterization of the growth kinetics of wildtype and vaccine strains of
LSDV on MDBK cells found approximately 2log10 PFU/mL increase in
virus over two days in a one-step growth curve and 5log10 PFU/mL
increase over three days in a multi-step growth curve. Virus increase
was seen in both the cell pellet and the supernatant suggesting that
LSDV virions are released as EEV, however the virions detected in the
supernatant could also represent IMVs released from lysed cells.
Antibodies that specifically neutralize IMVs of LSDV are required in
order to investigate this further.
The attenuated (Neethling) strain of LSDV is widely used as a live-
attenuated vaccine for the control of LSD. The growth of this strain to
high titres on MDBK cells suggests that MDBK cells are suitable for use
in the production of live-attenuated LSDV vaccines. The growth of a
wildtype strain of LSDV also to a high titre in MDBK cells suggests
MBDK cells are also suitable in a diagnostic setting for isolation of LSDV
from clinical samples.
The recommended method for detecting neutralizing antibodies to
LSDV is currently the serum neutralization test (SNT) using a read-out
of tissue culture infectious dose (TCID50) (OIE, 2019). This method is
often used for viruses which do not form easily identifiable plaques in
tissue culture. The sera dilution at which 50 % of replicates (usually
wells or plates) exhibit cytopathic effect is designated the TCID50 (Reed
and Muench, 1938). We developed a plaque-based Immunofluorescent
Virus Neutralization Test (IFVNT) by adapting previously published
methods for quantification of neutralizing antibodies to other pox-
viruses. The IFVNT incorporated a fluorescence-based detection method
instead of the traditional crystal violent stain. Foci were labelled using
an anti-LSDV074 antibody coupled with a fluorescently tagged anti-
bovine secondary antibody and visualised with epifluorescence micro-
scopy. The fluorescently-labelled foci were easier and quicker to count
compared to crystal violet-stained foci, and foci quantification was less
subjective than detection of CPE in a traditional SNT. The IFVNT was
shown to detect neutralizing antibodies in four experimentally-in-
oculated calves, including two animals which did not develop clinical
disease. The ability to count individual foci at different sera dilutions
enables endpoint neutralization titers to be determined, but also allows
for more discriminating measurements to be made such as the PRNT50
value which is the concentration of serum to reduce the number of
plaques by 50 % compared to the serum free virus. An assay using a
peroxidase staining methodology has recently been developed for the
detection of both neutralizing and total binding antibodies to LSDV by
Immunoperoxidase Monolayer Assay (IPMA) on OA3.T cell lines
(Haegeman et al., 2019). Detection of neutralizing antibodies provides
Fig. 3. Quantification of neutralizing antibodies to LSDV using an immuno-
fluorescent virus neutralization test (IFVNT). Serum collected at 21 days post
inoculation from five calves experimentally challenged with LSDV was tested
by IFVNT. Individual fluorescent foci were counted (using 50 foci as a max-
imum value) at each dilution and plotted. The clinical outcome of the LSDV
inoculation in each calf is noted on the right of the figure. Calf #1 was a non-
inoculated in-contact control.
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information about the function of antibodies present in the sera and can
be used to extrapolate levels of protection in the animal, which is the
major advantage of the assay over ELISA-based methods for detecting a
serological response to LSDV. However, the neutralization assays re-
main unsuited to a high throughput format as they are more time
consuming and technically challenging compared to a simple ELISA.
Neutralization assays remain more suited to research purposes rather
than, for example, post-vaccination monitoring.
MDBK cells were also used to develop a protocol for preparation of
DNA for whole genome sequencing of LSDV. The starting material was
treated with benzonase and the LSDV genomic DNA was extracted from
cell lysates partially purified through sucrose cushion ultracentrifuga-
tion. Viral genome DNA extraction from a crude extract of infected cells
usually results in low quality DNA, high host DNA contamination and
consequently reduction in the length and number of reads obtained
from a single viral genome sequencing run. Our protocol is inexpensive,
rapid and allowed recovery of sufficient genomic viral DNA for short
read sequencing using Illumina platforms from just one LSDV-infected
175 cm2 flask of MDBK cells. Whilst some degree of host-genome con-
tamination was observed, an average of 32–148 fold coverage was
achieved, allowing variant calling in 98.9–99.95 % of the genome
(short-read sequencing was unable to resolve the highly repetitive re-
gions at the ends of LSDV).
The rapid geographic expansion of LSD into Europe and Asia since
2012 has increased its impact on global agriculture and resulted in
more research laboratories studying LSDV. This paper provides details
of new methods which will improve the breadth of research into LSDV
and promote standardization of protocols across laboratories. The other
two species of the capripoxvirus genus are SPPV and GTPV, both im-
portant pathogens of small ruminants in low and middle income
countries in Africa and Asia. Initial studies have indicated that these
viruses also grow to high titers on MDBK cells and form foci similar to
LSDV. The protocols described in this paper are therefore likely to be
easily adapted for GTPV and SPPV.
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